Inmed to present at canaccord genuity's 5th annual global cannabis conference on may 11th, 2021

Vancouver, british columbia, may 04, 2021 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm; tsx:in), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and leading the clinical development of cannabinol (“cbn”), today announced that eric. a. adams, president and ceo of inmed, will be presenting at canaccord genuity's 5th annual global cannabis conference on tuesday, may 11th, which is being held virtually this year. details on the conference and how to participate are below.
INM Ratings Summary
INM Quant Ranking